The global pollen allergy market is currently valued at $5850.8 million in 2023 and is expected to grow at a 4.2% CAGR. Because of technological advancements in healthcare, the market is expected to reach US$ 8828.6 million by 2033.
The rise in the number of patients suffering from pollen-based allergies, specifically hay fever, drives market growth. Furthermore, the growing number of patients, particularly children, is fueling the global pollen allergy market. Rapid urbanisation in developing countries will be a major factor driving the growth of the pollen allergies market during the forecast period.
Request Sample Copy of Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-16236
Increased greenhouse gas emissions can cause pollen-induced reparative disease, which is expected to dampen the growth of the pollen allergies market.
Corticosteroids dominated the pollen allergy market in terms of revenue share, and their use as a first-line treatment is expected to contribute to market growth.
Because of the increased prevalence of allergies and awareness of therapy, North America has dominated the global pollen allergy market. Europe is expected to have the world’s second-largest pollen allergy market. Increasing disease awareness among people is another major factor that may boost market growth in this region.
Key Takeaways from the Market Study
- As of 2023, the pollen allergy market was valued at US$ 5850.8 Million
- From 2023 to 2033, the pollen allergy industry is poised to grow at a 4.2% CAGR
- By 2033, the pollen allergy market is slated to reach a valuation of US$ 8828.6 Million
- Based on therapeutic drug class, Corticosteroids dominated the pollen allergy market in 2023 with a revenue share of 35.5%.
- China is poised to yield a CAGR of 3.8% with respect pollen allergy in 2033
“Technological advancement in healthcare and increase in the prevalence of allergic rhinitis and rise in the number of patients especially children suffering from pollen allergies expected to radically transform the pollen allergy market in the coming years,” comments an analyst at FMI.
Ask an Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-16236
Competitive Landscape
Some of the leading manufacturers and players assessed in the global pollen allergy market are bioMerieux SA, HOB Biotech Group Corp Ltd, Alcon, HYCOR Biomedical, Inc, Immunomic Therapeutics, Quest Diagnostics Incorporated, Omega Diagnostics Group PLC, Siemens Healthcare Private Limited, Stallergenes Greer, Lincoln Diagnostics, Inc. and others
Manufacturers and players functional in the global pollen allergy market are adopting various corporate growth strategies such as new product launches, mergers and acquisitions, and geographical expansion, among others.
- In July 2022 – Stallergenes Greer, a global healthcare company specialising in allergen immunotherapy (AIT), today announced positive data from its EfficAPSI real-world study. Presented at the 2022 European Academy of Allergy and Clinical Immunology (EAACI) congress in Prague (Czech Republic), the real-world study confirmed significant benefit of sublingual liquid allergen immunotherapy treatment (AIT) on the onset and worsening of asthma in patients with allergic rhinitis.
- Lincoln Diagnostics offers a painless option for skin allergy testing with the Multi-Test PC (pain control). This test still provides high sensitivity, high specificity, and low variability in results but with virtually no pain.
More Valuable Insights Available
FMI, in its new offering, presents an unbiased analysis of the pollen allergy market, presenting historical demand data (2018 to 2022) and forecast statistics for the period of 2023 to 2033.
The study divulges essential insights on the pollen allergy market by Product Type (Instruments, Consumables, Services) by Allergen Type (Food, Inhaled, Drug, Other) by Therapeutics Drug Class (Antihistamines, Decongestants, Corticosteroids, Mast Cell Stabilizers, Leukotriene Inhibitors, Nasal Anticholinergics, Immunomodulators, Auto injectable Epinephrine, Immunotherapy) by End-User (Diagnostic Laboratories, Hospitals) by Region – Global Forecast 2023 to 2033.
Buy Now@ https://www.futuremarketinsights.com/checkout/16236
About Future Market Insights (FMI)
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs
